High frequency of Coxsackie-B-virus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity.
about
The role of infections in autoimmune diseaseSaffold virus, an emerging human cardiovirus.Echovirus 4 and type 1 diabetes mellitus.Evaluation of RT-PCR and immunohistochemistry as tools for detection of enterovirus in the human pancreas and islets of Langerhans.The pancreatic beta cell surface proteome.Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetesComparative evaluation of immunoglobulin M neutralizing antibody response in acute-phase sera and virus isolation for the routine diagnosis of enterovirus infectionEnterovirus infection of human islets of Langerhans affects β-cell function resulting in disintegrated islets, decreased glucose stimulated insulin secretion and loss of Golgi structureSubclass restriction of human enterovirus antibodiesSaffold virus, a novel human Cardiovirus with unknown pathogenicity.Tropism Analysis of Two Coxsackie B5 Strains Reveals Virus Growth in Human Primary Pancreatic Islets but not in Exocrine Cell Clusters In Vitro.Coxsackievirus B3-induced acute pancreatitis: analysis of histopathological and viral parameters in a mouse modelInfection of human islets of Langerhans with two strains of Coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway.Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology.Modulation of innate immunity in human pancreatic islets infected with enterovirus in vitro.Circulating Class II Transplantation Antigen-Expressing T Lymphocytes in Children with Insulin-Dependent Diabetes Mellitus at Diagnosis
P2860
Q22242631-5FD29B3E-5EAE-4A02-85C5-ECEF2F34E066Q30244703-6C5C4AAB-9990-4530-B838-23B36F2AFF10Q34119658-BB6D69E7-B4DC-4ED7-97B9-1B9C25F259AAQ34195258-7C272EA1-9697-40A2-B9CA-DB557F7C567DQ36013553-895CB421-A2A6-4B4D-927E-5EEB492E4CF6Q36216936-28103520-46D8-474E-B31C-88F3BCD63220Q37171301-3A0CFDA1-1B1B-4B3B-95EE-701427A06599Q37177400-31EEBBC5-CB8D-4FCF-9990-C91A9F6FB946Q37216416-80282571-CAD7-4806-ACAD-C2044284A7F1Q37960473-8BE923A8-7760-465E-923F-6796D701786EQ40819406-BA2E6E1E-552D-40BE-B771-273EA6113A2DQ41989233-EBE45110-DE1A-4CDA-8266-9085E98F324BQ42254652-93A53ED2-60DE-40D5-B0AB-17FE9DB28C97Q44177462-2E3A631D-75F6-4BE7-9FCB-07DCC049CC8CQ45417818-B1452D71-746F-48DB-90EE-1A9AA722C79DQ57352193-D295F40A-F4CD-49B8-991F-09FC122F55F5
P2860
High frequency of Coxsackie-B-virus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
High frequency of Coxsackie-B- ...... od of high diabetes morbidity.
@en
High frequency of Coxsackie-B- ...... od of high diabetes morbidity.
@nl
type
label
High frequency of Coxsackie-B- ...... od of high diabetes morbidity.
@en
High frequency of Coxsackie-B- ...... od of high diabetes morbidity.
@nl
prefLabel
High frequency of Coxsackie-B- ...... od of high diabetes morbidity.
@en
High frequency of Coxsackie-B- ...... od of high diabetes morbidity.
@nl
P2093
P356
P1476
High frequency of Coxsackie-B- ...... od of high diabetes morbidity.
@en
P2093
Diderholm H
P304
P356
10.1002/JMV.1890170303
P577
1985-11-01T00:00:00Z